The episode discusses various news topics including a teleprompter scandal, a bridge collapse trial verdict, FDA approval of a new drug, and a political conviction in Russia.
(0:10): White House Teleprompter Scandal: Insider Trading Allegations Spark Regulatory Debate on Prediction Markets (1:45): Morandi Bridge Collapse Trial: Former CEO Sentenced, Victims' Families Seek Justice in Genoa Verdict (3:21): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients (5:16): Russian Opposition Leader Boris Nadezhdin Convicted, Barred from Parliamentary Race (6:45): EU Court Ruling Limits Platform Immunity, Holds YouTube Liable for Gambling Ad Content To subscribe visit https://www.brief.news . For more updates in your inbox each morning visit www.brief.news . Image credit: Local News Live